Notifications
Clear all

Plerixafor


dumbcritic
(@dumbcritic)
Joined: 5 years ago
Posts: 104
Topic starter  

The drug was administered continuously by I.V. for one week to 24 patients with either pancreatic or MSS CRC (both low tumour mutational burden types) and was shown to induce an integrated immune response https://www.pnas.org/content/early/2020/10/27/2013644117

 

Another trial testing a slightly different drug, chemo, and an anti-PD-1 (keytruda) showed activity in patients with pancreatic https://www.nature.com/articles/s41591-020-0880-x


Daniel liked
Quote
Daniel
(@daniel)
Admin
Joined: 6 years ago
Posts: 1046
 

Great! Thanks a lot!

I shortly discussed Plerixafor 5 years ago https://www.cancertreatmentsresearch.com/plerixafor-mozobil/

Kind regards,
Daniel


ReplyQuote
Share: